1. Incidence of type 2 diabetes mellitus and hyperlipidemia in patients prescribed dasatinib or nilotinib as first- or second-line therapy for chronic myelogenous leukemia in the US. (1st February 2018) Authors: Franklin, Meg; Burns, Leah; Perez, Samuel; Yerragolam, Deepak; Makenbaeva, Dinara Journal: Current medical research and opinion Issue: Volume 34:Number 2(2018) Page Start: 353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗